Prognostic and Predictive Factors in Elderly Patients With Glioblastoma: A Single-Center Retrospective Study.
Ontology highlight
ABSTRACT: Glioblastoma (GBM) is the most common primary malignant intracranial tumor and the median age at diagnosis is 65 years. However, elderly patients are usually excluded from clinical studies and age is considered as an independent negative prognostic factor for patients with GBM. Therefore, the best treatment method for GBM in elderly patients has remained controversial. Elderly GBM patients (≥ 60 years old) treated between January 2015 and December 2019 were enrolled in this study. Medical records were reviewed retrospectively, and clinicopathological characteristics, treatments, and outcomes were analyzed. A total of 68 patients were included, with a median age of 65.5 years (range: 60-79). The median preoperative Karnofsky performance scale (KPS) score was 90 (range 40-100) and median pos
SUBMITTER: Liu J
PROVIDER: S-EPMC8841486 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA